跳到正文
原文
Nature Reviews Immunology· Yong Jiang·· 2026-10-09精选AI 评分74

LAG3 检查点功能及其治疗靶向作用机制综述

LAG3 checkpoint function and its mechanism of action in therapeutic targeting

AI 导读

LAG3 通过 tonic 与配体诱导信号通路等新定义的机制抑制 T 细胞活性,且已有针对其的靶向治疗探索。Nature Reviews Immunology 的这篇综述总结了这些治疗进展、生物标志物策略与新兴机会。原文链接:https://www.nature.com/articles/s41577-026-01359-2

推荐理由

综述梳理了 LAG3 经 tonic 与配体诱导通路抑制 T 细胞的信号机制,并汇总其在癌症与自身免疫病中的靶向治疗进展。

正文 · 原文

Nature Reviews Immunology, Published online: 09 October 2026; doi:10.1038/s41577-026-01359-2

This Review explores how the immune checkpoint receptor lymphocyte activation gene 3 (LAG3) suppresses T cell activity through newly defined signalling mechanisms, including tonic and ligand-induced pathways. The Review highlights therapeutic advances, biomarker strategies and emerging opportunities to target LAG3 in cancer and autoimmune disease.

来源:Nature Reviews Immunology · nature.com